TL;DR
- Babe Beverages won Gold at the 2025 World Kombucha Awards but has only 18K Instagram followers - the brand is a secret.
- Customers keep saying the same three things: "no stevia," "way less sugar than other brands," and "clean energy without the crash."
- The drinks aisle is shifting: kombucha is slowing down, yerba mate is the new energy drink, and prebiotic sodas are eating the gut-health story.
- 23% of US households have a GLP-1 user today - Babe's 12oz no-sugar yerba mate line is accidentally perfect for this market.
- The next $10M lives in four moves: GLP-1 repositioning (easy), convenience store distribution (hard but huge), louder Brazilian founder story (easy), and one Latin prebiotic soda test (medium).
- Guayakí's convenience store business grew 22% last year and now makes up 40%+ of their total sales - that's where the real money is.
What Customers Are Actually Saying
Strip away the marketing and three things come up again and again in Babe's reviews and on Amazon:
- "No stevia." People are sick of stevia. They hate the aftertaste. Babe sweetens lightly with organic cane sugar, and customers notice. This is a real moat and Babe isn't shouting about it.
- "Way less sugar." Customers think Babe is lower-sugar than competitors. That perception is the whole sale. It's also exactly what GLP-1 users (Ozempic, Wegovy) are looking for right now.
- "Tastes like a drink, not medicine." Babe customers love the tropical fruit flavors (POG, Maui Wowie, Sandia, Blue Amazon). They don't want vinegar-bomb kombucha or earthy-tea energy drinks. They want fruit. Cold. On the beach.
That's the customer. That's the wedge.
Where the Market Is Going
Four shifts are reshaping the drinks aisle right now. Babe touches all four.
Kombucha is slowing. It's still growing (13.6% a year in the US), but Olipop and Poppi are stealing the gut-health story. Poppi sold to PepsiCo for $1.95B. Olipop is valued at $1.85B. They're cheaper, sweeter, and easier to understand than kombucha. The kombucha brands that win from here are the ones that don't rely on "gut health" as the whole pitch.
Yerba mate is the new energy drink. Guayakí (now Yerba Madre) has 85% of the category and is exploding in convenience stores (up from 0% to 40%+ of their business in five years). 7-Eleven, QuikTrip, ampm: they're all adding it. This is the fastest-growing lane in beverage energy, and Babe already has a yerba mate line. It just isn't in the right stores.
GLP-1 is changing what people drink. 23% of US households already have someone on Ozempic or similar. By 2030, that's 35% of all food and beverage sales. These people want small cans, low sugar, low calories, and natural energy. Babe's 12oz no-added-sugar yerba mate line already fits that description. The product exists. The positioning doesn't.
People want tropical, Latin, and beach flavors. Jarritos, Topo Chico, aguas frescas: Latin flavors are mainstreaming fast. The Hispanic market has $2.7 trillion in buying power and grew 23% in a decade. Babe is a Brazilian-founded brand with tropical flavors. That's a gift the founders haven't fully opened.
Babe's Permission to Play
Before jumping into where to grow, the honest question: what has Babe earned the right to do?
Strong assets:
- A Gold Medal from the biggest kombucha competition in the world (2025)
- Two Brazilian founders who actually grew up drinking yerba mate, not a brand that borrowed the story
- Tropical flavors nobody else has (POG, Maui Wowie, Blue Amazon, Sandia)
- A real "no stevia, low sugar" credibility that customers already believe
- Nationwide Sprouts distribution as a base
Weak spots:
- Only 18K followers on Instagram (the brand is a secret)
- No convenience store footprint to speak of
- Still mostly a West Coast brand
- Small team, small budget
Babe is a good product people haven't heard of yet. That's the gap.
The Four Moves That Unlock $10M+
Move 1: Turn the 12oz No-Sugar Line Into the "GLP-1 Drink"
What it is: Babe already sells a 12oz no-added-sugar yerba mate line. Low calorie. Low sugar. Natural caffeine. Small can. That is, accidentally, exactly what people on Ozempic are looking for. Repackage and reposition it as the drink you reach for when you can't drink much but want it to count.
Why now: GLP-1 users are cutting sugary drinks, energy drinks, and alcohol. They want smaller cans. They want functional. Babe built that product before anyone asked. No reformulation needed. Just new messaging, new shelf story, and a simple claim: "Small can. Real energy. No sugar added."
How big: $500K to $1M a year within 18 months, and it lifts every other SKU on the shelf.
Easy or hard: Easy. This is a 90-day move. Mostly packaging and marketing.
Move 2: Get the Yerba Mate Into Convenience Stores
What it is: Follow Guayakí's playbook. Get Babe's 12oz yerba mate cans into 7-Eleven, Circle K, ampm, and regional convenience chains, starting in California, Arizona, Nevada, Texas.
Why now: Convenience is where yerba mate is actually growing. Guayakí's c-store business grew 22% last year. CLEAN Cause just got into 678 7-Elevens. The shelf is expanding and Babe isn't on it. The gap between Guayakí and Babe isn't the product. It's the distribution.
How big: This is the biggest prize on the list. 2,000 c-store doors at $6K per door per year is $12M in wholesale revenue. Even getting to 500 doors is a multi-million dollar revenue line.
Easy or hard: Hard. Takes 12-24 months. Requires a c-store sales team, distributor deals, and slotting budget. But this is where the real money is.
Move 3: Tell the Brazilian Story Louder
What it is: Babe's founders are Brazilian. They actually drink yerba mate. They grew up with it. Guayakí built an entire empire on yerba mate heritage storytelling, and Babe has a more personal, more specific version of the same story that they almost never tell. Put the founders on camera. Show the Brazilian side. Connect the dots between Brazil and San Diego.
Why now: Founder-led content is the cheapest and best-performing marketing in CPG right now. Olipop, Poppi, Liquid Death, Ghia: they all did this. 18K Instagram followers is not a ceiling. It's a signal that the brand has been quiet.
How big: Hard to put a dollar on this directly, but it makes every other move work better. Without story, the distribution push in Move 2 is just another can on the shelf.
Easy or hard: Easy. This is content work. No R&D. No inventory.
Move 4: Test One Latin-Flavored Prebiotic Soda (Don't Bet the Farm On It)
What it is: Poppi and Olipop own cream soda and cola flavors in the prebiotic space. Nobody owns tamarindo, horchata, guanábana, or pitanga. Test one SKU in a Latin tropical flavor, prebiotic-fiber forward, priced at $2.29 to compete with modern soda.
Why now: The prebiotic soda category is hot, but it's also starting to feel crowded with the same flavors. The Latin lane is wide open. And it fits Babe's existing flavor DNA better than any other brand that could enter it.
How big: If it works, $2-3M in wholesale revenue in year 2. If it doesn't, a real market signal. Test before you build.
Easy or hard: Medium. Needs real R&D work (prebiotic fiber isn't Babe's current stack) and maybe a sub-brand to avoid confusing the core kombucha shopper. Do this last, not first.
What to Skip
One honest "don't do this" earns more trust than ten "do this" recommendations.
Don't add protein kombucha or adaptogens. The functional-stacking arms race (collagen, ashwagandha, lion's mane, protein) is being won by brands with $50M R&D budgets and clinical claims. Babe is a flavor brand, not a pharma brand. Every adaptogen SKU you add dilutes what customers actually love: the tropical fruit, the low sugar, the beach feeling. Let the bigger brands fight that battle. Stay in your lane.
The Growth Map
| Move | Timing | Size | Difficulty |
|---|---|---|---|
| 1. GLP-1 repositioning of 12oz line | 0-6 months | $500K-$1M | Easy |
| 2. Convenience store yerba mate push | 6-24 months | $5-12M | Hard |
| 3. Louder Brazilian founder story | 0-6 months | Multiplier on everything else | Easy |
| 4. Test one Latin prebiotic soda SKU | 12-24 months | $2-3M if it works | Medium |
Do Moves 1 and 3 first. They're cheap, fast, and make everything else better. Move 2 is where the real revenue is, but it needs a 12-month runway. Move 4 only after Moves 1-3 are working.
Combined, these four moves are a $10-15M revenue ladder over 36 months on a base of what Babe looks like today. That's not a growth plan. That's a different company.
Where Lexsis Fits
Three reasons growth plans like this fail even when the market is right:
1. No one inside the company sees the signals together. Customer reviews live in one tool. Competitor launches live in trade press. Category data lives in SPINS. Search trends live in SimilarWeb. Social conversations live on Reddit and TikTok. By the time a growth team pulls all that into a deck, the data is three weeks old and the window is closed. Lexsis puts all of it in one feed, updated daily, ranked by opportunity size.
2. No one knows which customers to test with first. Every move in this report has a seed cohort inside Babe's existing customer base. For Move 1, it's the customers already buying the 12oz line and talking about weight loss in reviews. For Move 2, it's the ZIP codes where Babe over-indexes on DTC. Lexsis finds those people before Babe spends a dollar on launch.
3. No one simulates the second-order effects before committing. If Babe launches a Latin prebiotic soda, does it grow the business or eat into kombucha sales? If they reposition the 12oz line for GLP-1, do they win new customers or confuse existing ones? Lexsis models that before R&D spends 9 months and $200K on the wrong answer.
The hard part is never finding the opportunity. It's ranking them right, moving on the best one first, and knowing what happens next.
What to Do Next
Book a 20-minute demo at trylexsis.com. We'll show you the exact customer signals and category data for a brand like Babe, ranked by what to do first.
FAQ
Is Babe Beverages really positioned for $10M+ growth?
Yes, but only if they move on the four opportunities outlined in this report. The product, the founders, and the flavors are already there. The gap is distribution (especially convenience stores where yerba mate is exploding) and positioning (the GLP-1 opportunity is wide open). Guayakí's convenience store business grew 22% last year - that's the proof the lane exists.
Why is the GLP-1 market such a big deal for Babe?
23% of US households already have someone on Ozempic or similar, and by 2030 that's projected to be 35% of all food and beverage sales. These people want small cans, low sugar, low calories, and natural energy. Babe's 12oz no-added-sugar yerba mate line already fits that description perfectly. No reformulation needed - just new messaging.
What makes Babe different from other kombucha brands?
Three things: (1) no stevia (customers hate stevia aftertaste), (2) perceived as lower-sugar than competitors, and (3) tropical fruit flavors that taste like beach drinks, not medicine. Plus, the founders are actually Brazilian and grew up with yerba mate - it's not borrowed heritage storytelling.
Why focus on convenience stores instead of just expanding in grocery?
That's where yerba mate is actually growing. Guayakí went from 0% to 40%+ of their business in convenience stores in five years. CLEAN Cause just got into 678 7-Elevens. The shelf is expanding, margins are good, and Babe isn't on it yet. 2,000 c-store doors at $6K per door per year is $12M in wholesale revenue.
Should Babe add adaptogens or functional ingredients?
No. The functional-stacking arms race (collagen, ashwagandha, lion's mane, protein) is being won by brands with $50M R&D budgets and clinical claims. Babe is a flavor brand, not a pharma brand. Every adaptogen SKU dilutes what customers actually love: the tropical fruit, the low sugar, the beach feeling. Stay in your lane.
